Core Scientific

CoreWeave (CRWV) shares plummeted 13% after CEO Mike Intrator cited data center delays impacting its full-year projections. While Intrator portrayed the issue as isolated, CNBC’s Jim Cramer suggested broader problems, potentially tied to Core Scientific (CORZ), whose shares also fell 7%. CoreWeave revised its 2025 revenue forecast downwards despite a strong third-quarter revenue growth of 134%. The market reacted to the ambiguity surrounding the delays’ extent and their potential impact on CoreWeave’s ability to fulfill major AI infrastructure contracts with companies like Meta and OpenAI.

CoreWeave’s CEO downplays the necessity of acquiring Core Scientific amidst shareholder opposition. ISS recommends voting against the deal, citing potential undervaluation. While CoreWeave won’t raise its offer, viewing the acquisition as a “nice to have”, not a “need to have”. A major Core Scientific shareholder also opposes the deal. The vote is scheduled for October 30. CoreWeave’s expansion through AI-related acquisitions aims to diversify service offerings beyond GPU power, capitalizing on the AI boom.